EUVIMEDEUVIMED entdecken
Crossref

Evaluation of late effects during a 21-year follow-up of pediatric Hodgkin lymphoma survivors: Experience of a pediatric cancer center in Turkey, as a developing country model

Nurdan Tacyildiz iD, Hatice M Cakmak iD, Emel Unal iD, Handan Dincaslan iD, Gulsah Tanyıldız iD, Sonay I Özdemir, Ömer Kartal, Yasin Yılmaz iD, Gulsan Yavuz iD, Işınsu Kuzu iD

Indian Journal of Cancer · 2024

DOI: 10.4103/ijc.ijc_912_20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Cancer, 2024. Verfasst von Nurdan Tacyildiz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology and Oncology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara /Turkey. Hauptthemen laut MEDLINE: Hodgkin Disease, Cancer Survivors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long-term survivors of Hodgkin lymphoma (HL) are at risk of developing a range of late effects, with a second malignant neoplasm and cardiovascular diseases being the leading causes of death in these patients. The present study aims to evaluate the late side effects in children with HL. Materials and Methods: Out of 53 HL patients, we assessed the long-term effects of childhood HL survivors (HLSs; n = 50) diagnosed between 1998 and 2019. Patient data related to chronic health conditions, and sociodemographic characteristics were compared with their siblings ( n = 56).

Results

The cumulative overall survival (OS) at 1, 5, and 10 years from diagnosis was 98.1 ± 1.9%, 93.3 ± 3.8%, and 93.3 ± 3.8%, respectively. Groups of HLSs and their siblings were matched according to age and gender. Compared with siblings, survivors had will be changed as ‘a higher frequency of nephrotoxicity ( P = 0.02)’, cardiotoxicity ( P = 0.12), thyroid dysfunction ( P = 0.001), health care service usage ( P < 0.01), limitation of physical function ( P = 0.01), and pulmonary disease ( P = 0.01). The control group of siblings had a higher incidence of marital status ( P < 0.01), parenthood ( P = 0.01), and smoking habit ( P = 0.03). Thyroid dysfunction was associated with neck radiotherapy ( P < 0.01). No secondary neoplasm was detected. In relapsed, refractory setting ( n = 10), autologous transplantation ( n = 9) is performed after a complete remission. Brentuximab vedotin with or without bendamustine and rituximab is also used in selected patients.

Conclusions

Increased number of chronic health conditions and social problems point to the significance of long-term follow-up of HLSs. We are currently preparing a survivorship guideline appropriate for Turkey’s conditions. Implications for Cancer Survivors: Renal, heart, pulmonary impairment, thyroid dysfunction, limitation in physical functioning, and deterioration in social status (marriage, having children, education).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseCancer SurvivorsHumansMaleFemaleChildTurkeyFollow-Up StudiesAdolescentDeveloping CountriesAdultChild, PreschoolYoung Adult

Autor:innen und Institutionen

  • Division of Pediatric Hematology and Oncology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara /Turkey.
  • Division of Pediatric Hematology and Oncology, Department of Pediatrics, Gülhane Training and Research Hospital, Ankara /Turkey.
  • Department of Patology, Ankara University Faculty of Medicine, Ankara /Turkey.

ORCID-Profile: Nurdan Tacyildiz, Hatice M Cakmak, Emel Unal, Handan Dincaslan, Gulsah Tanyıldız, Yasin Yılmaz, Gulsan Yavuz, Işınsu Kuzu

Zitieren

APA

Tacyildiz, N., Cakmak, H. M., Unal, E., Dincaslan, H., Tanyıldız, G., Özdemir, S. I., Kartal, Ö., Yılmaz, Y., Yavuz, G., & Kuzu, I. (2024). Evaluation of late effects during a 21-year follow-up of pediatric Hodgkin lymphoma survivors: Experience of a pediatric cancer center in Turkey, as a developing country model. Indian Journal of Cancer. https://doi.org/10.4103/ijc.ijc_912_20

Vancouver

Tacyildiz N, Cakmak HM, Unal E, Dincaslan H, Tanyıldız G, Özdemir SI, et al. Evaluation of late effects during a 21-year follow-up of pediatric Hodgkin lymphoma survivors: Experience of a pediatric cancer center in Turkey, as a developing country model. Indian Journal of Cancer. 2024. doi:10.4103/ijc.ijc_912_20

BibTeX
@article{Tacyildiz2024,
  author = {Tacyildiz, Nurdan and Cakmak, Hatice M and Unal, Emel and Dincaslan, Handan and Tanyıldız, Gulsah and Özdemir, Sonay I and Kartal, Ömer and Yılmaz, Yasin and Yavuz, Gulsan and Kuzu, Işınsu},
  title = {Evaluation of late effects during a 21-year follow-up of pediatric Hodgkin lymphoma survivors: Experience of a pediatric cancer center in Turkey, as a developing country model},
  journal = {Indian Journal of Cancer},
  year = {2024},
  doi = {10.4103/ijc.ijc_912_20}
}
Kostenlos starten →